| Basics |
Aptose Biosciences, Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology.
|
| IPO Date: |
April 1, 1992 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$4.36M |
| Activated in VL: |
False |
| Average Daily Range |
| Avg Daily Range: |
$0.10 | 3.61%
|
| Avg Daily Range (30 D): |
$0.12 | 3.66%
|
| Avg Daily Range (90 D): |
$0.08 | 5.21%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.68M |
| Avg Daily Volume (30 D): |
.02M |
| Avg Daily Volume (90 D): |
6.5M |
| Trade Size |
| Avg Trade Size (Sh.): |
325 |
| Avg Trade Size (Sh.) (30 D): |
136 |
| Avg Trade Size (Sh.) (90 D): |
1,080 |
| Institutional Trades |
| Total Inst.Trades: |
16 |
| Avg Inst. Trade: |
$1.04M |
| Avg Inst. Trade (30 D): |
$M |
| Avg Inst. Trade (90 D): |
$M |
| Avg Inst. Trade Volume: |
M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-38.31
|
$-2.61
|
$-34.9
|
|
Diluted EPS
|
$-38.31
|
$-2.61
|
$-34.9
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -21.33M
|
$ -5.54M
|
$ -1.59M
|
|
Operating Income / Loss
|
$
|
$
|
$
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -.27M
|
$ M
|
$ -1.26M
|
|
PE Ratio
|
|
|
|
|
